These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 9751337

  • 41. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
    Stein JP, Penson DF.
    BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
    [Abstract] [Full Text] [Related]

  • 42. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.
    Kamat AM, Gee JR, Dinney CP, Grossman HB, Swanson DA, Millikan RE, Detry MA, Robinson TL, Pisters LL.
    J Urol; 2006 Mar; 175(3 Pt 1):881-5. PubMed ID: 16469571
    [Abstract] [Full Text] [Related]

  • 43. Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.
    Kouba EJ, Lentz A, Wallen EM, Pruthi RS.
    Urol Oncol; 2009 Mar; 27(5):486-90. PubMed ID: 18555706
    [Abstract] [Full Text] [Related]

  • 44. Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma.
    Kondylis FI, Demirci S, Ladaga L, Kolm P, Schellhammer PF.
    J Urol; 2000 Apr; 163(4):1120-3. PubMed ID: 10737479
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
    Gupta A, Lotan Y, Bastian PJ, Palapattu GS, Karakiewicz PI, Raj GV, Schoenberg MP, Lerner SP, Sagalowsky AI, Shariat SF, Bladder Cancer Research Consortium.
    Urology; 2008 Feb; 71(2):302-7. PubMed ID: 18308108
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Contemporary management of stage T1 transitional cell carcinoma of the bladder.
    Soloway MS, Sofer M, Vaidya A.
    J Urol; 2002 Apr; 167(4):1573-83. PubMed ID: 11912367
    [Abstract] [Full Text] [Related]

  • 50. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M, Nitzke T, Helke C, Vogler H, Hoschke B.
    Scand J Urol Nephrol; 2004 Apr; 38(3):231-5. PubMed ID: 15204377
    [Abstract] [Full Text] [Related]

  • 51. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T, Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [Abstract] [Full Text] [Related]

  • 52. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?
    Brauers A, Buettner R, Jakse G.
    J Urol; 2001 Mar; 165(3):808-10. PubMed ID: 11176474
    [Abstract] [Full Text] [Related]

  • 53. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.
    Holmäng S, Hedelin H, Anderström C, Johansson SL.
    J Urol; 1995 Jun; 153(6):1823-6; discussion 1826-7. PubMed ID: 7752327
    [Abstract] [Full Text] [Related]

  • 54. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Jun; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 55. Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder.
    Dalbagni G, Parekh DJ, Ben-Porat L, Potenzoni M, Herr HW, Reuter VE.
    BJU Int; 2007 Feb; 99(2):281-5. PubMed ID: 17155984
    [Abstract] [Full Text] [Related]

  • 56. Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?
    Weiss C, Wolze C, Engehausen DG, Ott OJ, Krause FS, Schrott KM, Dunst J, Sauer R, Rödel C.
    J Clin Oncol; 2006 May 20; 24(15):2318-24. PubMed ID: 16710030
    [Abstract] [Full Text] [Related]

  • 57. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG.
    J Urol; 2009 May 20; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [Abstract] [Full Text] [Related]

  • 58. Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder.
    Esrig D, Freeman JA, Stein JP, Skinner DG.
    Semin Urol Oncol; 1997 Aug 20; 15(3):154-60. PubMed ID: 9394910
    [Abstract] [Full Text] [Related]

  • 59. Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
    Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Lotan Y, Vazina A, Gupta A, Sagalowsky AI, Lerner SP, Schoenberg MP, Bladder Cancer Research Consortium.
    J Urol; 2006 May 20; 175(5):1645-9; discussion 1649. PubMed ID: 16600721
    [Abstract] [Full Text] [Related]

  • 60. Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy?
    Thalmann GN, Markwalder R, Shahin O, Burkhard FC, Hochreiter WW, Studer UE.
    J Urol; 2004 Jul 20; 172(1):70-5. PubMed ID: 15201740
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.